Myriad Genetics Inc.
MYGN | NASDAQ
$4.01
+$0.12 (+3.08%)
At close: Sep 21, 2026, 4:00 PM ET
$4.01
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $367.4M
Enterprise Value $474.04M
Beta 1.68
Average Volume 1.88M
Shares Outstanding (Diluted) 94.8M
Shares Change YoY 2.49%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US62855J1043
Price Performance
Price Change 1M 25.3%
Price Change 3M -13.4%
Price Change 6M -14.3%
Price Change YTD -34.7%
Price Change 1Y -48.9%
Price Change 3Y -75.9%
Price Change 5Y -88.0%
1M CAGR (ann.) 22.3%
1Y CAGR (ann.) -47.4%
5Y CAGR (ann.) -34.9%
All-Time CAGR -5.6%
Valuation
PE Ratio -3.37
Forward PE 36.09
PEG Ratio -0.05
Forward PEG 0.15
PS Ratio 0.47
Forward PS 0.50
PB Ratio 1.25
P/FCF Ratio -344.31
P/Adj. FCF Ratio -23.52
P/OCF Ratio 50.12
EV/Sales 0.59
EV/EBIT -8.33
EV/EBITDA -8.16
EV/FCF -430.94
Earnings Yield -29.7%
FCF Yield -0.3%
Adj. FCF Yield -4.3%
Financial Health
Net Debt $95.3M
Total Debt $210.5M
Cash & Short-Term Investments $115.2M
Total Assets $638.9M
Current Ratio 2.21
Quick Ratio 1.98
Debt / Equity Ratio 0.69
Debt / EBITDA -3.62
Debt / FCF -191.36
OCF / Debt 0.04
Interest Coverage -6.01
Altman Z-Score -0.71
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 68.8%
Operating Profit Margin -11.6%
EBITDA Margin -5.6%
Net Profit Margin -14.0%
FCF Margin -0.1%
Adj. FCF Margin -2.0%
SBC / Revenue 3.6%
SBC Impact (per share) -1363.6%
Returns
Return on Assets -17.6%
Return on Equity -32.6%
Return on Invested Capital -19.1%
Return on Capital Employed -19.4%
Return on Tangible Assets -24.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 4.9%
Revenue CAGR 5Y 9.7%
Revenue CAGR 10Y 0.7%
EPS CAGR 3Y 12.8%
EPS CAGR 5Y -14.9%
EPS CAGR 10Y -32.7%
FCF CAGR 3Y 111.0%
FCF CAGR 5Y 42.2%
FCF CAGR 10Y -136.3%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 36
EPS Growth Next 3Y 19.1%
Revenue Growth Next 3Y 4.8%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $2.90
Price Target Upside -27.7%
Cash Flow
Operating Cash Flow $7.7M
Free Cash Flow $-1.1M
Adj. Free Cash Flow $-16.1M
FCF Per Share -$0.09
OCF Per Share $0.08
OCF/S Ratio 1.0%
Income Statement
Revenue $806.6M
Gross Profit $555.2M
Operating Income $-93.2M
EBITDA $-58.1M
Net Income $-112.6M
EPS (Diluted) -$1.19
Revenue / Employee $298.74K
Profit / Employee $-41.7K
Employees 2,700
Add to Watchlist
Select watchlists to add or remove MYGN